Cancer

Title Average Ratingsort descending
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer........ 0.00%
Aging: gene silencing or gene activation? 0.00%
Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones 0.00%
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing 0.00%
Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retar 0.00%
Teratological evaluation of Ukrain in hamsters and rats 0.00%
A pilot study of adjuvant bevacizumab and chemotherapy after neoadjuvant chemotherapy for high-risk breast cancer. 0.00%
Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. 0.00%
Breast Cancer 0.00%
Evaluation of mutagenic, genotoxic and transforming properties of Ukrain 0.00%
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort s 0.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative.... 0.00%
Breast Cancer Treatment 0.00%
WITHDRAWN: Multi-agent chemotherapy for early breast cancer. 0.00%
Homeopatic therapy in Cancer Treatment 0.00%
Gemcitabine 0.00%
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. 0.00%
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhib 0.00%
Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain. 0.00%
Preliminary pharmacokinetic studies of Ukrain in rats 0.00%
PSMA - Lutetium Treatment 0.00%
High Dose Intravenous Vitamin C 0.00%
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) stud 0.00%
Dentists, dental nurses, and brain tumours 0.00%
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. 0.00%
Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro. 0.00%
Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carci 0.00%
IV Artesunate 0.00%
Removed because of suspicion of scientific fraud: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. 10.00%
Herbal Based Cancer Therapies 10.00%
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. 20.00%
The immunomodulating preparation Ukrain does not induce anaphylactic sensitization in mice and guinea pigs 20.00%
Mistletoe as a treatment for cancer. Has no proved benefit, and can cause harm 20.00%
Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report) 20.00%
Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer. 20.00%
Oral metronomic chemotherapy using cyclophosphamide in metastatic patients (pts) after standard treatment: Results of a randomiz 25.00%
Bioavailability of sorafenib tablets administered as a liquid suspension. 30.00%
A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followe 30.00%
Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. 30.00%
The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy 30.00%
Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. 30.00%
Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice. 30.00%
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the 30.00%
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of m 30.00%
Pharmacology and safety factors affecting use of flat (rather than weight-based) dosing of tesetaxel, an orally administered.... 30.00%
Outpatient administration of high-dose methotrexate for osteosarcoma treatment in Brazil. 30.00%
Correlation between prior therapeutic dendritic cell vaccination and the outcome of patients with metastatic melanoma treated... 30.00%
A phase II study of two dosing regimens of GSK 1363089 (GSK089), a dual MET/VEGFR2 inhibitor, in patients (pts) with papillar... 30.00%
Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats 40.00%
Pancreatic cancer stem cells - insights and perspectives. 40.00%
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. 40.00%
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer. 40.00%
A phase I study of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer. 40.00%
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. 40.00%
Serum cytokines in pancreatic cancer: Correlation with outcome 40.00%
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. 40.00%
Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. 40.00%
Control of cancer-associated inflammation and survival: Results from a prospective randomized phase II trial in gastric cancer. 40.00%
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. 40.00%
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer. 40.00%
Long term outcomes following surgical resection of myxopapillary ependymomas. 40.00%
Mistletoe in conventional oncological practice: exemplary cases. 40.00%
Circulating tumor and endothelial cells as pharmacodynamic biomarkers in a phase I clinical trial of intravenous bevacizumab.... 40.00%
Ifosfamide, carboplatin, and etoposide (ICE) in combination with regional hyperthermia (RHT) in chemotherapy-pretreated non..... 40.00%
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Onco 40.00%
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplat 40.00%
In vitro and in vivo antiproliferative activity of laherradurin and cherimolin-2 of Annona diversifolia Saff. 40.00%
Hepatocyte growth factor as inducer of gefitinib resistance in non-small cell lung cancer harboring EGFR activating mutations. 40.00%
Ependymoma. 40.00%
Enhancement of macrophage tumouricidal activity by the alkaloid derivative 40.00%
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) 40.00%
Inhibition of MIF Leads to Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells. 40.00%
Melatonin 45.00%
Phase I adjuvant trial of multi-epitope p53 vaccine for patients with squamous cell carcinoma of the head and neck (SCCHN): A pr 45.00%
MET in small cell lung carcinoma (SCLC): Effects of a MET inhibitor in SCLC cell lines and prognostic role of MET status in pati 50.00%
Evaluation of recombinant bacillus Calmette-Guerin expressing pertussis toxin in bladder cancer. 50.00%
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. 50.00%
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. 50.00%
Ukrain (NSC-631570) influences on bone status: a review. 50.00%
Systematic review: Cyclo-oxygenase-2 in human oesophageal adenocarcinogenesis. 50.00%
Ukrain in the treatment of urethral recurrent carcinoma (case report) 50.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Modification of antinociceptive action of morphine by Ukrain in rodents 50.00%
Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model. 50.00%
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, 50.00%
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung 50.00%
A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin.... 50.00%
Long-term safety of BLP25 liposome vaccine (L-BLP25) in patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC). 50.00%
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. 50.00%
Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies.... 50.00%
A study of the influence of a novel drug Ukrain on in vivo effects of low-dose ionizing radiation 50.00%
Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain 50.00%
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u 50.00%
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy 50.00%
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer. 50.00%
Chemoradiotherapy in malignant glioma: standard of care and future directions. 50.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities 50.00%
Inhibition of angiogenesis by non-toxic doses of temozolomide. 50.00%
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. 50.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary 50.00%

Pages